1988
DOI: 10.1111/j.1471-4159.1988.tb01134.x
|View full text |Cite
|
Sign up to set email alerts
|

Developmental and Age‐Related Changes in Rat Brain Glycosaminoglycans

Abstract: The quantities of each major class of glycosaminoglycan were determined in rat cerebrum from postnatal day 5 to 30 months of age. Chondroitin sulphate, dermatan sulphate, heparan sulphate, heparin, and hyaluronate were found, but no keratan sulphate was detected. Large and rapid changes in glycosaminoglycan content were observed during the period of brain maturation, and thereafter relatively steady levels were maintained until after the age of 12 months. The most remarkable change in the aged rat cerebrum was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
48
1

Year Published

1993
1993
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(52 citation statements)
references
References 38 publications
3
48
1
Order By: Relevance
“…This assay has been used with success to measure FCD values for comparison with FCD predictions in tissues modelled as triphasic mixture materials, such as cartilage and aorta (Lu et al 2007;Azeloglu et al 2008). While GAGs may not represent the entirety of the FCD found within brain (other contributions may come from negatively charged DNA, proteins and matrix molecules), there is a significant amount of different sulphated proteglycans in brain, the majority of which contain chondroitin sulphate (Margolis et al 1975(Margolis et al , 1976Jenkins & Bachelard 1988;Lander 1993;Koppe et al 1997;Costa et al 2007). Much of this sulphated GAG, especially at later stages of development, has been localized within the cytoplasm of neurons and astrocytes (Margolis et al 1979;Alvarado & Castejon 1984;Aquino et al 1984;Sames & Hoyer 1992).…”
Section: Discussionmentioning
confidence: 99%
“…This assay has been used with success to measure FCD values for comparison with FCD predictions in tissues modelled as triphasic mixture materials, such as cartilage and aorta (Lu et al 2007;Azeloglu et al 2008). While GAGs may not represent the entirety of the FCD found within brain (other contributions may come from negatively charged DNA, proteins and matrix molecules), there is a significant amount of different sulphated proteglycans in brain, the majority of which contain chondroitin sulphate (Margolis et al 1975(Margolis et al , 1976Jenkins & Bachelard 1988;Lander 1993;Koppe et al 1997;Costa et al 2007). Much of this sulphated GAG, especially at later stages of development, has been localized within the cytoplasm of neurons and astrocytes (Margolis et al 1979;Alvarado & Castejon 1984;Aquino et al 1984;Sames & Hoyer 1992).…”
Section: Discussionmentioning
confidence: 99%
“…HA proved to be the dominant GAG in the preterm brain, accounting for more than 60% of the GAGs, but its relative amount decreased gradually after birth at term gestation to reach the adult level of about 40% [32,34]. GAGs, especially HA, have been implicated in the morphogenesis and maturation of the brain by providing highly hydrated matrices for cellular growth, proliferation, and migration [31,33] as well as for cell-to-cell interaction [35].…”
Section: Discussionmentioning
confidence: 99%
“…Content and composition of brain GAGs undergo developmental changes [29][30][31][32][33][34]. Total GAGs are constant at early stages of development and thereafter increase steadily to attain a plateau by the postneonatal period.…”
Section: Discussionmentioning
confidence: 99%
“…Normal brain ECM is composed mostly of hyaluronic acid, a nonsulfated glycosaminoglycan, and proteoglycans carrying either chondroitin sulfate (CSPG) or heparan sulfate (HSPG) glycosaminoglycan side chains, along with the more recently identified reelin and tenascin glycoproteins (4,5). Although aging (6)(7)(8), pathological insults (9, 10), or genetic modifications (11) resulting in altered brain ECM content are often associated with changes in ECS volume fraction, the ability of ECM components to specifically bind and slow the migration of diffusing substances in the ECS remains an open question. A direct ECM effect on extracellular diffusion (e.g., sequestration or slowing of a diffusing substance) has been postulated for proteins capable of binding HSPG (12,13), but little evidence exists for this phenomenon in vivo.…”
mentioning
confidence: 99%